Micro Guide Catheters Market To Record Excellent Growth With 6.2% CAGR by 2030

Pune, India, 2022/MRFR Press Release/- Market Research Future has published a half-cooked research report on the Global Micro Guide Catheters Market.

Global Micro Guide Catheters Market – Overview

Increased development in diagnostic and minimally invasive therapies is pushing the development of micro guide catheters. Market reports associated with the medical device industry have been made accessible by Market Research Future which produces reports on other industry verticals that summaries the recent market scenarios. the Micro Guide Catheters Market is anticipated to reach USD 78,200 Million by 2030 at a 6.2 % CAGR during the forecast period 2022-2030

The traction for micro guide catheters is gaining momentum currently as procedures that involve the use of minimally invasive device. The market is boosted by the growing incidence of cardiovascular and urological diseases globally. The market for micro guide catheters is expected to expand substantially as the catheters guarantee a great deal of safety and efficiency in the high-risk procedures. The reduced recovery time ensured by micro guide catheters is expected to further impel the development of the market in the forecast period.

Segmental Analysis

The micro guide catheters market is segmented on the basis of types, application, end-user, and region. On the basis of types, the market is segmented into over the wire micro guide catheters, and flow-directed micro guide catheters. The segmentation on the basis of application consist of neurovascular, cardiovascular, urology and other. On the basis of end user, the micro guide catheters market consists of clinics, hospital, among others. The regions covered in the market are Asia Pacific, Europe, North America, and the Middle East and Africa.

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Micro Guide Catheters Market Research Report

Detailed Regional Analysis

The regions included in the micro guide catheter market globally are Europe, North America, Asia Pacific, and the Middle East and Africa. Owing to the high volume of medical procedures conducted through catheterization in the North American region has made the region a leader in the micro guide catheter globally. The accessibility to infrastructure and technology has provided a significant boost for the expansion of this market in the European and North American region.

Competitive Analysis

The market is at an optimally beneficial level and will be able of generating superior worth for the companies in the market and its shareholders. Although, the market has also greatly neutralized the market challenges and thus is encouraging a surge in the number of firms in the market. The management inclinations in the market are emphasizing the level of growth that can be achieved in the present market scenario.  The modification of the product assortment in the market is growing the opportunity for the progress of the market. The capacity to utilize the economies of scale is further proving to be beneficial for comprehensive market growth. The expansion outlines are revised in tandem to the customer likings to realize the greatest growth, and in the long run, viability.

The noteworthy competitors shaping the micro guide catheters market are Micro Therapeutics Inc. (India), LuMend Corporation (US), BrosMed Medical, Covidien AG (Ireland), Terumo Europe N.V. (Belgium), Baylis Medical Medtronic (Canada), Diasolve Ltd. (UK), ASAHI INTECC Company Limited (Thailand), Volcano Corporation (US), Merit Medical Systems Inc (US), ACIST Medical Systems (US), Boston Scientific Corporation (US), Cordis Corporation (US), Cook Medical Inc. (US) and Navilyst Medical Inc. (US) to name a few.

Industry Updates:

July 2018 EchoNous recently declared that it had received an FDA 510(k) clearance for its EchoNous Vein ultrasound device intended to develop peripheral IV catheter placements. The EchoNous Vein system is planned to provide real-time, clear images at depths of one to five centimeters for visualizing superficial and deeper veins. The company also specified that it plans to incorporate the EchoNous Vein with the company’s present Uscan intelligent medical tool to form the EchoNous platform and to unite the products under its Signostics brand in the EchoNous moniker.